{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-028260","form_type":"8-K","ticker":"GTBP","cik":"0000109657","company_name":"GT Biopharma, Inc.","filed_at":"2022-10-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.596359+00:00","generated_at":"2026-06-23T04:00:08.643856+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"GT Biopharma shareholders vote to reduce authorized common stock from 750M to 250M shares","bullets":["Special meeting held Oct 10, 2022; 17,442,945 of 31,092,498 shares represented (56.1%).","Proposal to ratify amendment reducing authorized common stock from 750M to 250M shares passed.","Vote: 17,201,108 For, 227,621 Against, 14,216 Abstain.","The amendment was previously proposed at the 2022 Annual Meeting as Proposal No. 4."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-028260","json":"https://secwatch.observer/filing/0001493152-22-028260.json","markdown":"https://secwatch.observer/filing/0001493152-22-028260.md","text":"https://secwatch.observer/filing/0001493152-22-028260.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/109657/000149315222028260/0001493152-22-028260-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/109657/000149315222028260/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T04:00:08.643856+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}